Neuromuscular disorders: therapeutic advances

Lancet Neurology

Volumn 6, Issue 1, 2007, Pages 18-19

  Talbot, Kevin ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; BINDING PROTEIN; CHOLINESTERASE INHIBITOR; DYSTROPHIN; MONOCLONAL ANTIBODY; PROTEIN; PROTEIN DOK 7; TAR DNA BINDING PROTEIN 43; UBIQUITIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN CORTEX; CONGENITAL MYASTHENIC SYNDROME; DUCHENNE MUSCULAR DYSTROPHY; FRONTOTEMPORAL DEMENTIA; GEL ELECTROPHORESIS; GENE DELIVERY SYSTEM; GENE MUTATION; HUMAN; MOTONEURON; MOTOR NEURON DISEASE; MYASTHENIA GRAVIS; NEUROMUSCULAR DISEASE; NEUROMUSCULAR SYNAPSE; PARKINSON DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE;

EID: 33845330917     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(06)70667-6     Document Type: Note

References (5)

1. Neumann M., Sampathu D., Kwong L., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314 (2006) 130-133
2. Beeson D., Higuchi O., Palace J., et al. Dok-7 mutations underlie a neuromuscular junction synaptopathy. Science 313 (2006) 1975-1978
3. Alter J., Lou F., Rabinowitz A., et al. Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology. Nat Med 12 (2006) 175-177
4. Denti M., Rosa A., D'Antona G., et al. Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model. Proc Natl Acad Sci USA 103 (2006) 3758-3763
5. Bourke S., Tomlinson M., Williams T., Bullock R., Shaw P., and Gibson G. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial. Lancet Neurol 5 (2006) 140-147